Symptoms and immunoglobulin development in hospital staff exposed to a SARS‐CoV‐2 outbreak. Issue 7 (18th June 2020)

• Record Type: Journal Article
• Authors: Brandstetter, Susanne; Roth, Samra; Harner, Susanne; Buntrock‐Döpke, Heike; Toncheva, Antoaneta A.; Borchers, Natascha; Gruber, Rudolf; Ambrosch, Andreas; Kabesch, Michael
• Editors: Kalaycı, Ömer
• Is Part Of: Pediatric allergy and immunology. Volume 31:Issue 7(2020)
• Page Start: 841
• Page End: 847
• Publication Date: 2020-06-18
• Subjects: antibody response -- COVID‐19 outbreak -- COVID‐19 outbreak -- COVID‐19 pandemic -- healthcare workers -- immunoglobulin development -- infection chain -- SARS‐CoV‐2; Allergy in children -- Periodicals; Immunologic diseases in children -- Periodicals; 617
• DOI: 10.1111/pai.13278
• Languages: English
• ISSNs: 0905-6157

Abstract

Abstract: Background: Worldwide, the number of SARS‐CoV‐2 infections is increasing. Serological immunoglobulin tests may help to better understand the development of immune mechanisms against SARS‐CoV‐2 in COVID‐19 cases and exposed but asymptomatic individuals. The aim of this study was to investigate exposure to SARS‐CoV‐2, symptoms, and antibody responses in a large sample of healthcare workers following a COVID‐19 outbreak. Methods: A COVID‐19 outbreak among staff members of a major German children's and women's hospital was followed by massive RT‐PCR SARS‐CoV‐2 tests and provided the opportunity to study symptoms, chains of infection, and SARS‐CoV‐2–specific antibody responses (IgG and IgA) by ELISA. Study participants were classified as COVID‐19 cases, and persons with close, moderate, or no exposure to SARS‐CoV‐2 in the clinical setting, respectively. Results: Out of 201 study participants, 31 were COVID‐19 cases. While most study participants experienced many symptoms indicative for SARS‐CoV‐2 infection, anosmia and coughing were remarkably more frequent in COVID‐19 cases. Approximately 80% of COVID‐19 cases developed some specific antibody response (IgA and IgG) approximately 3 weeks after onset of symptoms. Subjects in the non‐COVID‐19 groups had also elevated IgG (1.8%) and IgA values (7.6%) irrespective of contact history with cases. Conclusion: We found that a significant number of diseased did not develop relevant antibody responses three weeks after symptom onset. Our data also suggest that exposure to COVID‐19 positive co‐workers in a hospital setting is not leading to the development of measurable immune responses in a significant proportion of asymptomatic contact persons.